MWF Mycobacteria antigens in occupational hypersensitivity pneumonitis
MWF 职业性过敏性肺炎中的分枝杆菌抗原
基本信息
- 批准号:8301478
- 负责人:
- 金额:$ 38.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project summary
Occupational hypersensitivity pneumonitis (HP) in machine workers has been
associated with mycobacteria that frequently colonize modern water-based metalworking
fluids (MWFs). HP is an immune-mediated lung disease caused by inhalation of
microbial antigens and is relatively poorly studied in terms of its diagnosis, pathogenesis,
and treatment. Overall goal of this study is to identify and characterize antigens
associated with HP-inducing potential of MWF mycobacteria species M. immunogenum
(MI) and M. chelonae (MC) and evaluate their potential for HP immunodiagnosis and
exposure assessment. In previous funding cycles, we have isolated multiple strains
(genotypes) of both the species with variable antigenic characteristics. We will test our
hypothesis that antigen diversity in MWF mycobacteria strains prevalent in commercial
MWF is responsible for differentially inducing the HP symptoms and underlying immune
response, and that the responsible specific antigens could form the basis for more
informative diagnosis and personal and environmental exposure assessment. The
specific aims are to: (1). Identify key antigens in MI and MC strains based on their
relative interaction with the host immune system in an optimized mouse model of HP;
(2). Recombinant production of the identified key antigens by cloning and protein
expression and generation of specific antibodies; (3). Investigate potential of the specific
antigens for early personal exposure assessment and immunodiagnosis in symptomatic
versus asymptomatic individuals; (4). Evaluate potential of the specific antigen(s) of
MWF mycobacteria for environmental exposure assessment (fluid monitoring). Relative
immunogenicity of the isolated different genotypes of MI (6) and MC (4) will be
compared based on HP induction potential and cell-mediated immune response using
our optimized mouse model and the putative protein antigens will be identified by
differential immunoproteomic profiling. The recombinantly expressed antigens will be
evaluated for their potential for immunodiagnosis using the mouse model and human
subjects, particularly in terms of differentiation of the asymptomatic (exposed) versus
symptomatic (HP patients) and for environmental exposure assessment. The resulting
information will help NORA's objectives by providing a set of tools for mycobacterial
exposure assessment and HP immunodiagnosis; these outcomes will facilitate future
epidemiological studies and development of prevention (vaccination) and intervention
strategies for MWF exposures in long-term.
项目摘要
机器工人的职业超敏性肺炎(HP)已经是
与经常定居现代水基金属加工的分枝杆菌相关
流体(MWF)。 HP是一种免疫介导的肺疾病
微生物抗原,就其诊断,发病机理而言,研究相对较差
和治疗。这项研究的总体目标是识别和表征抗原
与MWF分枝杆菌的诱导HP诱导潜力有关。
(MI)和M. chelonae(MC),并评估其HP免疫诊断的潜力和
暴露评估。在以前的资金周期中,我们有多种菌株
具有可变抗原特性的两个物种的(基因型)。我们将测试我们的
假设MWF分枝杆菌菌株中普遍存在的抗原多样性在商业中普遍存在
MWF负责差异诱导HP症状和潜在的免疫
反应,并且负责任的特定抗原可以构成更多的基础
内容丰富的诊断以及个人和环境暴露评估。这
具体目标是:(1)。根据它们的MI和MC菌株中的密钥抗原
在优化的HP小鼠模型中,与宿主免疫系统的相对相互作用;
(2)。通过克隆和蛋白质重组产生鉴定的关键抗原
特定抗体的表达和产生; (3)。调查特定的潜力
抗原早期个人暴露评估和有症状的免疫诊断
相对于无症状的个体; (4)。评估特定抗原的潜力
MWF分枝杆菌环境暴露评估(流体监测)。相对的
分离的不同基因型MI(6)和MC(4)的免疫原性将为
根据HP诱导电位和细胞介导的免疫反应进行比较
我们优化的小鼠模型和推定的蛋白质抗原将通过
差异免疫蛋白质分析。重组表达的抗原将是
评估使用小鼠模型和人类的免疫诊断潜力
受试者,特别是在无症状(暴露)与
有症状的(HP患者)和环境暴露评估。结果
信息将通过提供分生不清的工具来帮助NORA的目标
暴露评估和HP免疫诊断;这些结果将促进未来
流行病学研究和预防的发展(疫苗接种)和干预
长期接触MWF的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jagjit S Yadav其他文献
Jagjit S Yadav的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jagjit S Yadav', 18)}}的其他基金
Circulating Cell-free Antigens for Monitoring of Machining Fluids
用于监测加工液的循环无细胞抗原
- 批准号:
9979088 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别:
Circulating Cell-free Antigens for Monitoring of Machining Fluids
用于监测加工液的循环无细胞抗原
- 批准号:
10271234 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别:
FUNGAL P450 SYSTEMS IN BIODEGRADATION OF HIGHER PAHS-R01ES15543-01
真菌 P450 系统生物降解高级 PAHS-R01ES15543-01
- 批准号:
7527777 - 财政年份:2008
- 资助金额:
$ 38.28万 - 项目类别:
FUNGAL P450 SYSTEMS IN BIODEGRADATION OF HIGHER PAHS-R01ES15543-01
真菌 P450 系统生物降解高级 PAHS-R01ES15543-01
- 批准号:
7666234 - 财政年份:2008
- 资助金额:
$ 38.28万 - 项目类别:
FUNGAL P450 SYSTEMS IN BIODEGRADATION OF HIGHER PAHS-R01ES15543-01
真菌 P450 系统生物降解高级 PAHS-R01ES15543-01
- 批准号:
8066598 - 财政年份:2008
- 资助金额:
$ 38.28万 - 项目类别:
Genetic Determinants of Host Susceptibility to Pulmonary Anthrax
宿主对肺炭疽易感性的遗传决定因素
- 批准号:
7477723 - 财政年份:2007
- 资助金额:
$ 38.28万 - 项目类别:
Genetic Determinants of Host Susceptibility to Pulmonary Anthrax
宿主对肺炭疽易感性的遗传决定因素
- 批准号:
7256636 - 财政年份:2007
- 资助金额:
$ 38.28万 - 项目类别:
MWF Mycobacteria antigens in occupational hypersensitivity pneumonitis
MWF 职业性过敏性肺炎中的分枝杆菌抗原
- 批准号:
7886344 - 财政年份:2001
- 资助金额:
$ 38.28万 - 项目类别:
相似国自然基金
结核分枝杆菌espA、PPE57、modD抗原表位变异与其免疫逃逸的机制研究
- 批准号:82260004
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
结核分枝杆菌功能基因组T细胞抗原的筛选及自组装纳米疫苗的构建与免疫学研究
- 批准号:U22A20525
- 批准年份:2022
- 资助金额:259.00 万元
- 项目类别:联合基金项目
结核分枝杆菌RD区新功能性蛋白Rv1768(PE_PGRS31)的抗原性鉴定及其介导的逃逸机制的探讨
- 批准号:81701968
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
结核分枝杆菌PE_PGRS家族抗原PE_PGRS41调控宿主免疫应答的分子机制研究
- 批准号:81701979
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
敲除抑制自噬基因增强卡介苗介导的自噬对结核病的预防和机制
- 批准号:81772147
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
相似海外基金
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
使用纳米颗粒结合的抗原和佐剂在粘膜表面进行疫苗接种
- 批准号:
10587388 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis
非结核分枝杆菌和 B 细胞在异位生发中心刺激和肺结核免疫控制中的作用
- 批准号:
10569865 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
M. tuberculosis metabolites to activate human mucosal-associated invariant T cells
结核分枝杆菌代谢物可激活人粘膜相关的不变 T 细胞
- 批准号:
10737315 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine
开发新型佐剂 Th1 和 Th17 诱导亚基结核疫苗
- 批准号:
10576407 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Development of a highly-sensitive urine test for tuberculosis (TB) that detects diverse forms of urinary TB lipoarabinomannan (uLAM)
开发一种高灵敏度的结核病尿液检测方法,可检测多种形式的尿液结核菌脂阿拉伯甘露聚糖 (uLAM)
- 批准号:
10667871 - 财政年份:2022
- 资助金额:
$ 38.28万 - 项目类别: